Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
+4.81M
-
Total reported value, excl. options
-
$484M
-
Value change
-
+$83.8M
-
Number of buys
-
36
-
Number of sells
-
-26
-
Price
-
$18.40
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q1 2021
80 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q1 2021.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.43M shares), RTW INVESTMENTS, LP (2.65M shares), VIKING GLOBAL INVESTORS LP (2.12M shares), FRANKLIN RESOURCES INC (1.89M shares), VR Adviser, LLC (1.69M shares), Avidity Partners Management LP (1.68M shares), CITADEL ADVISORS LLC (1.26M shares), Logos Global Management LP (1.01M shares), BlackRock Inc. (990K shares), and JANUS HENDERSON GROUP PLC (876K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.